Welcome to LookChem.com Sign In|Join Free

CAS

  • or

50737-34-3

Post Buying Request

50737-34-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

50737-34-3 Usage

General Description

5-(Chloromethyl)-3-ethyl-1,2,4-oxadiazole is a chemical compound with a molecular formula of C5H7ClN2O. It is a heterocyclic compound that contains an oxadiazole ring with a chloromethyl and ethyl substituent. 5-(Chloromethyl)-3-ethyl-1,2,4-oxadiazole can be synthesized using various chemical reactions and is used as a building block in the synthesis of pharmaceuticals and agrochemicals. It also possesses potential biological activities and has been studied for its antimicrobial and antifungal properties. Additionally, it is a versatile intermediate in organic synthesis and can be used in the development of new materials and compounds with diverse applications. However, it is important to handle this compound with care as it is a potentially hazardous chemical that may cause harm if not handled properly.

Check Digit Verification of cas no

The CAS Registry Mumber 50737-34-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,7,3 and 7 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 50737-34:
(7*5)+(6*0)+(5*7)+(4*3)+(3*7)+(2*3)+(1*4)=113
113 % 10 = 3
So 50737-34-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H7ClN2O/c1-2-4-7-5(3-6)9-8-4/h2-3H2,1H3

50737-34-3Relevant articles and documents

Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same

-

Page/Page column 150-151, (2008/06/13)

The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1 and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 50737-34-3